Cargando…

Novel Insights and Therapeutics in Multiple Sclerosis

The last twelve years have witnessed the development of new therapies for relapsing-remitting multiple sclerosis that demonstrate increased efficacy relative to previous therapies. Many of these new drugs target the inflammatory phase of disease by manipulating different aspects of the immune system...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wagner, Catriona A., Goverman, Joan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000Research 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544373/ https://www.ncbi.nlm.nih.gov/pubmed/26339480 http://dx.doi.org/10.12688/f1000research.6378.1

Ejemplares similares

Pathogenic T cell cytokines in multiple sclerosis
por: Wagner, Catriona A., et al.
Publicado: (2019)

A Pathogenic Role for Myelin-Specific Cd8(+) T Cells in a Model for Multiple Sclerosis
por: Huseby, Eric S., et al.
Publicado: (2001)

Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms
por: Dixit, Aakanksha, et al.
Publicado: (2017)

Distinct T cell signatures define subsets of patients with multiple sclerosis
por: Johnson, Mark C., et al.
Publicado: (2016)

A Comprehensive Review on Neuroimmunology: Insights from Multiple Sclerosis to Future Therapeutic Developments
por: Eva, Lucian, et al.
Publicado: (2023)

New Insights into Multiple Sclerosis Mechanisms: Lipids on the Track to Control Inflammation and Neurodegeneration
por: Podbielska, Maria, et al.
Publicado: (2021)

Secondary Progressive Multiple Sclerosis: New Insights
por: Cree, Bruce A.C., et al.
Publicado: (2021)

Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis
por: Nheu, Danica, et al.
Publicado: (2022)

Investigation of a novel therapeutic approach in multiple sclerosis
por: Eniko, Biró, et al.
Publicado: (2013)

Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
por: Biernacki, Tamás, et al.
Publicado: (2020)

Oligodendrocyte Development and Regenerative Therapeutics in Multiple Sclerosis
por: Gacem, Nadjet, et al.
Publicado: (2021)

Insights into the Changing Perspectives of Multiple Sclerosis in India
por: Pandit, Lekha
Publicado: (2011)

Cell-based therapeutic strategies for multiple sclerosis
por: Scolding, Neil J, et al.
Publicado: (2017)

New Insights into Risk Genes and Their Candidates in Multiple Sclerosis
por: Shirai, Remina, et al.
Publicado: (2022)

Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications
por: Palle, Pushpalatha, et al.
Publicado: (2017)

PPAR-γ: Therapeutic Potential for Multiple Sclerosis
por: Drew, Paul D., et al.
Publicado: (2008)

Risk evaluation and monitoring in multiple sclerosis therapeutics
por: Clanet, Michel C, et al.
Publicado: (2014)

Experimental and Therapeutic Opportunities for Stem Cells in Multiple Sclerosis
por: Patani, Rickie, et al.
Publicado: (2012)

Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets
por: Govindarajan, Vaidya, et al.
Publicado: (2020)

Therapeutic Approaches to Insomnia and Fatigue in Patients with Multiple Sclerosis
por: Drerup, Michelle, et al.
Publicado: (2021)

Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status
por: Harris, Violaine K., et al.
Publicado: (2014)

Vaccination of multiple sclerosis patients during the COVID-19 era: Novel insights into vaccine safety and immunogenicity
por: Kim, Enoch, et al.
Publicado: (2022)

Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis
por: Gumkowska-Sroka, Olga, et al.
Publicado: (2023)

The Diversity of Astrocyte Activation during Multiple Sclerosis: Potential Cellular Targets for Novel Disease Modifying Therapeutics
por: Barmpagiannos, Konstantinos, et al.
Publicado: (2023)

New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab
por: Frau, Jessica, et al.
Publicado: (2018)

The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue
por: Kirby, Trevor O., et al.
Publicado: (2018)

Microglial Phagocytosis—Rational but Challenging Therapeutic Target in Multiple Sclerosis
por: Pinto, Maria V., et al.
Publicado: (2020)

Progressive multiple sclerosis: latest therapeutic developments and future directions
por: Faissner, Simon, et al.
Publicado: (2019)

Should mast cells be considered therapeutic targets in multiple sclerosis?
por: Pinke, Karen Henriette, et al.
Publicado: (2020)

The need for a strategic therapeutic approach: multiple sclerosis in check
por: Inojosa, Hernan, et al.
Publicado: (2022)

The Gut–Brain Axis as a Therapeutic Target in Multiple Sclerosis
por: Buga, Ana Maria, et al.
Publicado: (2023)

Therapeutic Advances in Multiple Sclerosis
por: Yang, Jennifer H., et al.
Publicado: (2022)

Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis
por: Heidker, Rebecca M., et al.
Publicado: (2017)

Novel insights into dendritic cells in the pathogenesis of systemic sclerosis
por: Carvalheiro, T., et al.
Publicado: (2020)

Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis
por: Ojeda-Hernández, Doddy Denise, et al.
Publicado: (2022)

B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions
por: Claes, Nele, et al.
Publicado: (2015)

State of the Art and Future Challenges in Multiple Sclerosis Research and Medical Management: An Insight into the 5th International Porto Congress of Multiple Sclerosis
por: Sá, María José, et al.
Publicado: (2020)

New immunopathologic insights into multiple sclerosis
por: Hemmer, Bernhard, et al.
Publicado: (2003)

Unraveling the Gut-Brain Axis in Multiple Sclerosis: Exploring Dysbiosis, Oxidative Stress, and Therapeutic Insights
por: Sharifa, Mouhammad, et al.
Publicado: (2023)

Tolerating the Nervous System: A Delicate Balance
por: Huseby, Eric S., et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_v7dabmi16kti1co30j8j52v17r